Table 2.
Associations between age at natural menopause and first non-fatal cardiovascular disease, coronary heart disease, and stroke events
Women (n) | Cardiovascular disease events (n) | Person-years (n) | Events per 1000 person-years (n) | Adjusted HR (95% CI)* | ||
---|---|---|---|---|---|---|
Cardiovascular disease | ||||||
Age at natural menopause (years) | ||||||
<40 | 3424 | 346 | 84 961·6 | 4·1 | 1·55 (1·38–1·73) | |
40–44 | 14 038 | 1216 | 372 142·8 | 3·3 | 1·30 (1·22–1·39) | |
45–49 | 48 061 | 3316 | 1 269 834·9 | 2·6 | 1·12 (1·07–1·18) | |
50–51 | 47 391 | 3016 | 1 303 876·1 | 2·3 | 1 (ref) | |
52–54 | 50 996 | 3146 | 1 429 883·3 | 2·2 | 0·96 (0·91–1·01) | |
≥55 | 28 662 | 1922 | 852 776·4 | 2·3 | 0·88 (0·83–0·93) | |
Premenopause or perimenopause | 108 913 | 3253 | 2 842 537·1 | 1·1 | 0·52 (0·48–0·56) | |
Trend p value† | .. | .. | .. | .. | <0·0001 | |
Coronary heart disease | ||||||
Age at natural menopause (years) | ||||||
<40 | 3419 | 253 | 85 414·1 | 3·0 | 1·52 (1·34–1·74) | |
40–44 | 14 022 | 881 | 373 417·4 | 2·4 | 1·30 (1·20–1·41) | |
45–49 | 48 016 | 2418 | 1 272 920·1 | 1·9 | 1·13 (1·06–1·20) | |
50–51 | 47 362 | 2180 | 1 307 497·1 | 1·7 | 1 (ref) | |
52–54 | 50 944 | 2260 | 1 432 324·2 | 1·6 | 0·96 (0·90–1·02) | |
≥55 | 28 628 | 1377 | 854 420·9 | 1·6 | 0·90 (0·85–0·97) | |
Premenopause or perimenopause | 108 902 | 2229 | 2 710 689·7 | 0·8 | 0·59 (0·53–0·65) | |
Trend p value† | .. | .. | .. | .. | <0·0001 | |
Stroke | ||||||
Age at natural menopause (years) | ||||||
<40 | 3412 | 126 | 86 474·8 | 1·5 | 1·72 (1·43–2·07) | |
40–44 | 13 993 | 416 | 376 099·8 | 1·1 | 1·32 (1·18–1·48) | |
45–49 | 47 892 | 1078 | 1 279 465·0 | 0·8 | 1·09 (1·00–1·18) | |
50–51 | 47 301 | 1018 | 1 31 4206·0 | 0·8 | 1 (ref) | |
52–54 | 50 868 | 1048 | 1 439 717·0 | 0·7 | 0·94 (0·86–1·02) | |
≥55 | 28 644 | 652 | 860 938·3 | 0·8 | 0·89 (0·81–0·99) | |
Premenopause or perimenopause | 108 805 | 1120 | 2 065 658·4 | 0·5 | 0·46 (0·40–0·52) | |
Trend p value† | .. | .. | .. | .. | <0·0001 |
HR=hazard ratio.
Cox proportional hazards models were used to estimate HRs and 95% CIs. All HRs were adjusted for age at last follow-up, ethnicity, education level, body-mass index, smoking status, hypertension status, and postmenopausal menopausal hormone therapy status, or oral contraception use in the premenopause or perimenopause group.
χ2 values of >50, with 6 degrees of freedom.